Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor

Molecular Pharmacology

Volumn 50, Issue 6, 1996, Pages 1658-1664

  Patel, Smita ^a   Patel, Shil ^a   Marwood, Rosemarie ^a   Emms, Frances ^a   Marston, Deborah ^a   Leeson, Paul D ^a   Curtis, Neil R ^a   Kulagowski, Janusz J ^a   Freedman, Stephen B ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIMETHYLAMINO 6,7 DIHYDROXYTETRALIN; 2 DIPROPYLAMINO 5,6 DIHYDROXYTETRALIN; 3 [[4 (4 IODOPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; ASCORBIC ACID; BUTACLAMOL; CHLORPROMAZINE; CLOZAPINE; DOMPERIDONE; DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE 4 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; INDOLE DERIVATIVE; IODINE 125; ISOBUTYLMETHYLXANTHINE; NEUROLEPTIC AGENT; QUINPIROLE; RADIOLIGAND; SEROTONIN RECEPTOR; SPIPERONE; SULPIRIDE; UNCLASSIFIED DRUG;

ARTICLE; DOPAMINERGIC SYSTEM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; SCHIZOPHRENIA;

ANIMALS; CELL LINE; DOPAMINE ANTAGONISTS; HUMANS; IODINE RADIOISOTOPES; KINETICS; PYRIDINES; PYRROLES; RADIOLIGAND ASSAY; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4;

EID: 0030460367     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kebabian, J. W., and D. B. Calne. Multiple receptors for dopamine. Nature (Lond.) 277:93-96 (1979).
2. Seeman, P. Dopamine receptor sequences: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7:261-284 (1992).
3. Baldessarini, R. J., and D. Tarsy. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu. Rev. Neurosci. 3:23-41 (1980).
4. Dearry, A. G., J. A. Gingrich, P. Falardeau, R. T. Fremeau, M. D. Bates and M. G. Caron. Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature (Lond). 347:72-76 (1990).
5. Bunzow, J. R., H. H. M. Van Tol, D. K. Grandy, P. Albert, J. Salon, M. Christie, C. A. Machida, K. A. Neve, and O. Civelli. Cloning and expression of a rat dopamine receptor. Nature (Lond.) 336:783-787 (1988).
6. Sokoloff, P., B. Giros, M.-P. Martres, M-L. Bouthenet, and J.-C. Schwartz. Molecular cloning and characterisation of a novel dopamine receptor (D3) as a target for neuroleptics. Nature (Lond.) 347:146-151 (1990).
7. Van Tol, H. H. M., J. R. Bunzow, H.-C. Guan, R. K. Sunahara, P. Seeman, B. Niznik, and O. Civelli. Cloning of a gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature (Lond.) 350:610-614 (1991).
8. Sunahara, R. K., H.-C. Guan, B. F. O'Dowd, P. Seeman, L. G. Laurier, G. Ng, S. R. George, J. Torchia, H. H. M. Van Tol, and H. B. Niznik. Cloning of the gene for a human D5 receptor with higher affinity for dopamine than D1. Nature (Lond.) 614-619 (1991).
9. Coward, D. M., A. Imperato, S. Urwyler, and T. G. White. Biochemical and behavioural properties of clozapine. Psychopharmacology 99:S6-S12 (1989).
10. Seeman, P., H.-C. Guan, and H. H. M. Van Tol. Dopamine D4 receptors elevated in schizophrenia. Nature (Lond.) 865:441-445 (1993).
11. 3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Brain Res. 681:109-116 (1995).
12. Murray, A. M., T. M. Hyde, M. B. Knable, M. M. Herman, L. B. Bigelow, J. M. Carter, D. R. Weinberger, and J. E. Kleinman. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J. Neurosci. 15:2186-2191 (1995).
13. Reynolds, G. P., and S. L. Mason. Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia. Eur. J. Pharmacol. 281: R5-R6 (1995).
14. Kulagowski, J. J., H. B. Broughton, N. R. Curtis, I. M. Mawer, M. P. Ridgill, R. Baker, F. Emms, S. B. Freedman, R. Marwood, S. Patel, S. Patel, C. I. Ragan, and P. D. Leeson. 3-[[4-(4-Chlorophenyl)piperazin-1-y1]-methyl]-1H-pyrrolo[2,3-b]pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. J. Med. Chem. 39:1941-1942 (1996).
15. Billard, W., V. Ruperto, G. Crosby, L. C. Iorio, and A. Barnett. Characterisation of the binding of 3H-SCH 23390, a selective D1 receptor antagonist ligand, in rat striatum. Life Sci. 35:1885-1893 (1984).
16. 3H]tolyl)guanidine: a selective ligand that labels σ-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc. Natl. Acad. Sci. USA 83:8784-8788 (1986).
17. Beer, M. S., J. A. Stanton, Y. Bevan, A. J. Reeve, L. J. Street, V. G. Matassa, R. J. Hargreaves, and D. N. Middlemiss. L-694,297: a potent 5HT1D receptor agonist. Br. J. Pharmacol. 110:1196-1200 (1993).
18. 2 receptor. Mol. Pharmacol. 38:604-609 (1990).
19. Lahti, R. A., D. L. Evans, N. C. Stratman, and L. M. Figur. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications. Eur. J. Pharmacol. 236:483-486 (1993).
20. O'Malley, K. L., S. Harmon, L. Tang, and R. D. Todd. The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol. 4:137-146 (1992).
21. Tang, L., R. D. Todd, A. Heller, and K. L. O'Malley. Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268:495-502 (1994).
22. Mansour, A., I. Meador-Woodruff, S. Burke, I. Bunzow, H. Akil, H. H. M. Van Tol, O. Civelli, and S. I. Watson. Differential distribution of D2 and D4 dopamine receptor mRNAs in the rat brain: an in situ hybridisation study. Soc. Neurosci. Abstr. 17:599 (1991).
23. Meador-Woodruff, I., A. Mansour, C. Work, H. H. M. Van Tol, D. Grandy, O. Civelli, and S. I. Watson. Localisation of D4 and DS dopamine receptor mRNAs in the human brain. Soc. Neurosci. Abstr. 17:599 (1991).
24. Mansour, A., J. H. Meador-Woodruff, J. R. Bunzow, O. Civelli, H. Akil, and S. Watson. Localisation of dopamine D2 receptor mRNA and pituitary: an in situ hybridisation-receptor autoradiographic analysis. J. Neurosci. 10: 2587-2601 (1990).
25. Bouthenet, M.-L., E. Souil, M.-P. Martres, P. Sokoloff, B. Giros, and J. C. Schwartz. Localisation of dopamine D3 receptor mRNA in the rat brain using in situ hybridisation histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 564:203-219 (1991).
26. Mrzljak, L., C. Bergson, M. Pappy, R. Huff, R. Levenson, and P. S. Goldman-Rakic. Localisation of dopamine D4 receptors in GABAergic neurons of primate brain. Nature (Lond.) 381:245-248 (1996.
27. 125I]epidepride. Eur. J. Pharmacol. 286:R3-R5 (1995).
28. Grigoridis, D., and P. Seeman. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide. J. Neurochem. 44:1925-1935 (1985).
29. 3H]sulpiride binding sites in rat striatal membrane preparations. J. Neurochem. 44:1925-1935 (1981).
30. Freedman, S. B., M. Beer, and E. A. Harley. Muscarinic M1, M2 receptor binding: relationship with functional efficacy. Eur. J. Pharmacol. 156: 133-142 (1988).
31. Freedman, S. B., S. Patel, R. Marwood, F. Emms, G. R. Seabrook, M. R. Knowles, and G. McAllister. Expression and pharmacological characterization of the human D3 dopamine receptor. J. Pharmacol. Exp. Ther. 268:417-426 (1994).
32. Onali, P., M. C. Olianas, and G. L. Gessa. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Mol. Pharmacol. 28:138-145 (1985).
33. Dal Toso, R., B. Sommer, M. Ewert, A. Herb, D. B. Pritchett, A. Bach, D. Shivers, and P. H. Seeburg. The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J. 8:4025-4034 (1989).
34. 125I]iodosulpride. Eur. J. Pharmacol. 118:211-219 (1985).
35. 125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain. J. Pharmacol. Exp. Ther. 257:1253- (1991).
36. 3H-raclopride. J. Neural Transm. 73:7-21 (1988).
37. Woodruff, G. N. ADTN: a potent dopamine receptor agonist. Trends Pharmacol. Sci. 3:59-61 (1982).
38. Woodruff, G. N., A. Davis, C. D. Andrews, and J. Poat. Dopamine receptors in the mammalian brain, in Recent Advances in Receptor Chemistry (F. Guattieri, M. Gianelli, and M. Melchiorre, eds.). Elsevier/North Holland, Amsterdam, 165-188 (1979).
39. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108 (1973).